Cargando…
Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
In 2012, it was estimated that 9180 people in the United States would die from melanoma and that more than 76,000 new cases would be diagnosed. Surgical resection is effective for early-stage melanoma, but outcomes are poor for patients with advanced disease. Expression of tumor-associated antigens...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072479/ https://www.ncbi.nlm.nih.gov/pubmed/24971166 http://dx.doi.org/10.1186/2051-1426-2-11 |